Brief: Gritstone Announces Updated Overall Survival Results From Granite Phase 1/2 Study

Gritstone bio

10/11/2022 14:38

Nov 10 (Reuters) - Gritstone bio Inc  GRTS.O :
    * GRITSTONE ANNOUNCES UPDATED OVERALL SURVIVAL RESULTS FROM
GRANITE PHASE 1/2 STUDY AND POSTER AT SITC 2022
    * GRITSTONE BIO - MEDIAN OS FOR PATIENTS WITH MSS-CRC WHO
HAD TWO
PRIOR LINES OF THERAPY AND HAD MOLECULAR RESPONSE WILL NOW
EXCEED 22 MONTHS

Source text for Eikon:  ID:nGNX394lFV 
Further company coverage:  GRTS.O 
 ((reuters.briefs@thomsonreuters.com;))